●founderWorth watching because regulatory responses to this testimony could impose restrictions on life-science AI products or require additional safeguards for biology-domain models.
●policyDirect congressional testimony from major lab CEOs creates pressure for biosecurity-specific AI regulation — watch for new compliance requirements around biology-adjacent model outputs.